Latest filing published 11 Mar 2026 for Aquestive Therapeutics, Inc.. Read the official filing
No signal scores available.
A. Ernest Toth Jr. discloses dealings in Aquestive Therapeutics, Inc. to SEC (Form 4). We count 5 filings; the first trade dates from 9 March 2023 and the latest from 9 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 11 March 2026 with a share grant in Aquestive Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations